Market Tracker

07/31 10:01pm ET

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
255.44 +2.98 / +1.18%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
255.35 -0.09 / -0.04%
 
Volume: 2.7K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-0.05% 3 years+40.66%
3 months+22.38% 5 years+36.23%
1 year+68.62% Since inception+19.13%
Data through 07/31/2015

Quote Details

Previous close$252.46
Open day’s range251.30 – 258.82
Net asset value (NAV)252.22 (07/30/2015)
Daily volume962,924
Average volume (3 months)1,145,457
Data as of 3:59pm ET, 07/31/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+36.23%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.421.74
Net assets$2.7B$2.0B
Average market cap$2.2B$37.5B
Average P/E--25.5
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.32%
KYTH KYTHERA Biopharmaceuticals Inc1.28%
ZIOP ZIOPHARM Oncology Inc1.19%
NVAX Novavax Inc1.16%
EPZM Epizyme Inc1.15%
BCRX BioCryst Pharmaceuticals Inc1.10%
PRTA Prothena Corporation PLC1.09%
RARE Ultragenyx Pharmaceutical Inc1.08%
CMRX Chimerix Inc1.06%
MDXG MiMedx Group Inc1.06%